Evoq Remedies Limited (BOM:543500)

Evoq Remedies Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 21, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	74	64	118	177	307	-
Market Cap Growth	-61.55%	-45.94%	-33.26%	-42.52%	-	-
Enterprise Value	71	89	130	282	345	-
Last Close Price	2.98	2.56	8.67	12.99	22.60	-
PE Ratio	4.38	72.27	26.06	10.91	28.17	-
PS Ratio	0.18	0.45	1.87	0.67	1.83	-
PB Ratio	0.17	0.14	0.47	0.71	1.33	-
P/TBV Ratio	0.17	0.14	0.47	0.71	1.33	-
P/FCF Ratio	2.61	-	2.22	-	-	-
P/OCF Ratio	2.39	-	2.22	-	-	-
EV/Sales Ratio	0.17	0.63	2.06	1.07	2.06	-
EV/EBITDA Ratio	3.74	50.33	21.03	12.33	-	-
EV/EBIT Ratio	3.88	69.52	21.28	12.35	23.57	-
EV/FCF Ratio	2.50	-	2.45	-	-	-
Debt / Equity Ratio	-	-	0.17	0.39	0.35	0.00
Debt / EBITDA Ratio	-	-	6.85	4.18	-	-
Debt / FCF Ratio	-	-	0.80	-	-	0.04
Asset Turnover	0.82	0.33	0.18	0.77	0.81	1.46
Inventory Turnover	20.66	4.90	0.61	13.73	29.53	74.41
Quick Ratio	0.62	1.61	0.16	1.72	2.80	0.94
Current Ratio	6.82	9.10	3.17	3.45	3.28	1.10
Return on Equity (ROE)	4.04%	0.25%	1.81%	6.75%	9.13%	186.89%
Return on Assets (ROA)	2.30%	0.18%	1.06%	4.19%	4.42%	8.71%
Return on Invested Capital (ROIC)	3.99%	0.24%	1.42%	5.19%	7.56%	194.11%
Return on Capital Employed (ROCE)	4.10%	0.30%	2.40%	9.20%	6.30%	128.20%
Earnings Yield	23.81%	1.38%	3.84%	9.17%	3.55%	-
FCF Yield	38.35%	-233.45%	45.02%	-24.67%	-89.92%	-
Buyback Yield / Dilution	-30.91%	-83.09%	-	-35.84%	-900.56%	-40.93%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.